Novo Nordisk A/S’s obesity shot Wegovy also prevents strokes, heart attacks and death. The price of those benefits is far ...

The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Glucagon-like peptide 1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Results from a new study showed people taking Wegovy (semaglutide) for weight loss were 33 percent less likely to die of COVID-19 than people taking placebo. They were also 15 percent less likely ...

If you buy through links on this page, we may earn a small commission. Here’s our process. Wegovy is a weight loss medication that you can only get with a prescription from a licensed healthcare ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates. The new ...

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday. Michael Siluk ...

The experimental medication has the potential to reduce hunger and slow stomach emptying even more so than drugs that are already on the market to treat obesity, like Wegovy. Novo Nordisk ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates. The new formulation ...